Compare DE Nora India with Similar Stocks
Dashboard
With ROE of 9.4, it has a Expensive valuation with a 3.2 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -3.90%, its profits have risen by 491.8% ; the PEG ratio of the company is 0.1
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Electrodes & Refractories
INR 419 Cr (Micro Cap)
34.00
35
0.51%
-0.60
9.42%
3.21
Total Returns (Price + Dividend) 
Latest dividend: 4.022704081632654 per share ex-dividend date: Sep-16-2026
Risk Adjusted Returns v/s 
Returns Beta
News

DE Nora India Ltd Downgraded to Sell Amid Mixed Financials and Technical Signals
DE Nora India Ltd, a micro-cap player in the Electrodes & Refractories sector, has seen its investment rating downgraded from Hold to Sell as of 18 Sep 2026. This decision follows a comprehensive reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite some encouraging financial results, the overall outlook has been tempered by valuation concerns and weakening technical indicators, prompting a cautious stance among investors.
Read full news article
DE Nora India Ltd Upgraded to Hold by MarketsMOJO on Technical and Financial Improvements
DE Nora India Ltd, a micro-cap player in the Electrodes & Refractories sector, has seen its investment rating upgraded from Sell to Hold by MarketsMOJO as of 7 September 2026. This revision reflects a combination of improved technical indicators, robust quarterly financial results, and a more balanced valuation profile despite some lingering concerns over long-term returns and sector challenges.
Read full news article
DE Nora India Ltd Downgraded to Sell Amid Mixed Financials and Technical Weakness
DE Nora India Ltd, a micro-cap player in the Electrodes & Refractories sector, has seen its investment rating downgraded from Hold to Sell as of 1 September 2026. This change reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite strong quarterly profit growth, the stock’s technical indicators and valuation metrics have raised caution among analysts, prompting a more conservative stance.
Read full news article Announcements 
De Nora India Limited - Other General Purpose
09-Dec-2019 | Source : NSEDe Nora India Limited has informed the Exchange regarding Certificate under Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
De Nora India Limited - Outcome of Board Meeting
13-Nov-2019 | Source : NSEDe Nora India Limited has informed the Exchange that in the Board meeting held on November 12, 2019, Unaudited Financial Results of the Company for the second quarter and half year ended September 30,2019 have been approved
De Nora India Limited - Updates
06-Nov-2019 | Source : NSEDe Nora India Limited has informed the Exchange regarding 'Pursuant Regulation 47 of SEBI (LODR) Regulations, 2015, Newspaper advertisement of the Notice of Board Meeting for taking on record the Unaudited Financial Results of the Company for the quarter ended September 30, 2019'.
Corporate Actions 
No Upcoming Board Meetings
DE Nora India Ltd has declared 40% dividend, ex-date: 16 Sep 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 2 FIIs (0.83%)
Oronzio De Nora International B.v. (53.68%)
Lalan Ajay Kapadia (1.41%)
37.46%
Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is 60.54% vs -38.70% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 1,098.44% vs -124.90% in Mar 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 106.57% vs 9.46% in Sep 2024
Growth in half year ended Sep 2025 is 15.58% vs -10.33% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 105.68% vs -15.91% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 687.27% vs -112.36% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 77.34% vs -7.07% in Mar 2025
YoY Growth in year ended Mar 2026 is 436.09% vs -91.11% in Mar 2025






